Evidence map›Paper›PMID 10623674›Full record

ArticleThe American journal of pathology2000

Apical plasma membrane mispolarization of NaK-ATPase in polycystic kidney disease epithelia is associated with aberrant expression of the beta2 isoform.

P D Wilson, O Devuyst, X Li, L Gatti, D Falkenstein, S Robinson, D Fambrough, C R Burrow

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 96 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Sensational site: the sodium pump ouabain-binding site and its ligands.American journal of physiology. Cell physiology · 2024
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. The Apical Localization of NaFrontiers in physiology · 2016
    Article
  11. Article
  12. Article
  13. Trafficking to the apical and basolateral membranes in polarized epithelial cells.Journal of the American Society of Nephrology : JASN · 2014
    Review
  14. Review
  15. Article
  16. Article
  17. Apicobasal polarity in the kidney.Experimental cell research · 2012
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

P D WilsonDepartment of Medicine, Mount Sinai School of Medicine, New York, New York 10029, USA. patwilson@SMTPlink.MSSM.edu
O Devuyst
X Li
L Gatti
D Falkenstein
S Robinson
D Fambrough
C R Burrow
Icahn School of Medicine at Mount Sinai · USMount Sinai Hospital · USJohns Hopkins University · USMount Sinai Medical Center · US

Funding

NERVE &MUSCLE MEMBRANESR01NS023241 · NINDS · JOHNS HOPKINS UNIVERSITY · PI FAMBROUGH, DOUGLAS M · 1985 to 2001
$948k
ROLE OF NAK-ATPASE AND POLCARITY DEFECTS IN ADPKD CYST FR01DK044833 · NIDDK · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI WILSON, PATRICIA D. · 1991 to 2002
$919k
NIDDK NIH HHS R01DK44833NINDS NIH HHS R01NS23241
6 · The paper itself

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is a common genetic disease of the kidney, characterized by cystic enlargement of renal tubules, aberrant epithelial proliferation, and ion and fluid secretion into the lumen. Previous studies have shown abnormalities in polarization of membrane proteins, including mislocalization of the NaK-ATPase to the apical plasma membranes of cystic epithelia. Apically located NaK-ATPase has previously been shown to be fully functional in vivo and in membrane-grown ADPKD epithelial cells in vitro, where basal-to-apical (22)Na transport was inhibited by application of ouabain to the apical membrane compartment. Studies were conducted with polymerase chain reaction-generated specific riboprobes and polyclonal peptide antibodies against human sequences of alpha1, alpha3, beta1, and beta2 subunits of NaK-ATPase. High levels of expression of alpha1 and beta1 messenger RNA were detected in ADPKD and age-matched normal adult kidneys in vivo, whereas beta2 messenger RNA was detected only in ADPKD kidneys. Western blot analysis and immunocytochemical studies showed that, in normal adult kidneys, peptide subunit-specific antibodies against alpha1 and beta1 localized to the basolateral membranes of normal renal tubules, predominantly thick ascending limbs of Henle's loop. In ADPKD kidneys, alpha1 and beta2 subunits were localized to the apical epithelial cell membranes, whereas beta1 was distributed throughout the cytoplasm and predominantly in the endoplasmic reticulum, but was not seen associated with cystic epithelial cell membranes or in cell membrane fractions. Polarizing, renal-derived epithelial Madin Darby canine kidney cells, stably expressing normal or N-terminally truncated chicken beta1 subunits, showed selective accumulation in the basolateral Madin Darby canine kidney cell surface, whereas c-myc epitope-tagged chicken beta2 or human beta2 subunits accumulated selectively in the apical cell surface. Similarly, human ADPKD epithelial cell lines, which endogenously expressed alpha1 and beta2 NaK-ATPase subunits, showed colocalization at the apical cell surface and coassociation by immunoprecipitation analysis. These results are consistent with a model in which the additional transcription and translation of the beta2 subunit of NaK-ATPase may result in the apical mislocalization of NaK-ATPase in ADPKD cystic epithelia.

Indexed as

AnimalsCell LineCell MembraneCell PolarityCells, CulturedDogsEpithelial CellsHumansIsoenzymesKidneyPolycystic Kidney DiseasesSodium-Potassium-Exchanging ATPaseTissue DistributionTranscription, GeneticIsoenzymesSodium-Potassium-Exchanging ATPase

Identifiers

PMID10623674
PMCPMC1868615
OpenAlexW2067648338

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.